Primary Periodic Paralysis is a rare genetic condition impacting 3,000-4,000 Americans characterized by repeated episodes of extreme muscle weakness or temporary paralysis, often triggered by ...

Primary Periodic Paralysis is a rare genetic condition impacting 3,000-4,000 Americans characterized by repeated episodes of extreme muscle weakness or temporary paralysis, often triggered by specific ...

Key products include Gvoke for severe hypoglycemia, Keveyis for Primary Periodic Paralysis, and Recorlev for Cushing's Syndrome, with Recorlev showing strong growth. The company has a promising ...

When acetazolamide, an agent used to treat hyperkalemic periodic paralysis, was inadvertently found to relieve a patient with the hypokalemic variety, he and another patient were observed to ...